Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

600
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
600
Cancer Prevention02:59

Cancer Prevention

7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancer Vaccines01:30

Cancer Vaccines

882
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
882

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-Based Organizations, Indian Health Services, and Rural Federally Qualified Health Center Collaborative: Patient navigation along the cancer care continuum.

Journal of health care for the poor and underserved·2026
Same author

Cancer Screening Adherence in the US by Smoking and Vaping Status, 2023.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Attention-based deep learning for analysis of pathology images and gene expression data in lung squamous premalignant lesions.

Genome medicine·2026
Same author

Opportunities and Challenges for Addressing Financial Hardship as an Integrated Part of Cancer Care Delivery.

Journal of the National Cancer Institute·2026
Same author

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Journal for immunotherapy of cancer·2026
Same author

Upregulation of an Epithelial miRNA Is Associated with Immune Evasion in Progressive Bronchial Premalignant Lesions.

Cancer immunology research·2026

Related Experiment Video

Updated: Dec 29, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.4K

Building a comprehensive cancer survivorship program.

Tessa Flores1, Kathryn M Glaser2, Douglas McDaniel2,3

  • 1Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Ecancermedicalscience
|February 4, 2020
PubMed
Summary

Cancer survivorship is growing due to better treatments. Comprehensive care plans are essential to manage survivors' long-term physical, emotional, and psychological needs.

Keywords:
cancer continuumcancer survivorshipintegrative medicinelong-term survivorsquality of life

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

710
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

589

Related Experiment Videos

Last Updated: Dec 29, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.4K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

710
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

589

Area of Science:

  • Oncology
  • Public Health
  • Healthcare Management

Background:

  • Increasing number of cancer survivors due to advancements in early detection and treatment.
  • Cancer survivorship presents unique long-term physical, emotional, psychological, and spiritual challenges.
  • Effective survivorship programming requires a multi-faceted approach.

Purpose of the Study:

  • To outline key components of a comprehensive, multi-disciplinary cancer survivorship care plan.
  • To emphasize the importance of addressing the holistic needs of cancer survivors.
  • To guide the development of robust survivorship programs.

Main Methods:

  • Review of current literature and best practices in cancer survivorship.
  • Discussion of essential elements for survivorship care coordination.
  • Identification of critical areas for clinician education and patient support.

Main Results:

  • Survivorship care must integrate clinical management, psychosocial support, and community provider communication.
  • Standardized protocols are needed for seamless care transitions.
  • Education for healthcare professionals across the continuum of care is vital.

Conclusions:

  • Developing comprehensive, multi-disciplinary cancer survivorship care is crucial for improving long-term outcomes.
  • Addressing the diverse needs of survivors requires coordinated efforts between oncology teams and primary care providers.
  • Enhanced survivorship programming leads to better quality of life for individuals living beyond cancer.